Connection
Brendan Frett to Administration, Oral
This is a "connection" page, showing publications Brendan Frett has written about Administration, Oral.
|
|
Connection Strength |
|
 |
|
 |
|
0.055 |
|
|
|
-
Tran P, Moccia M, Wang X, Brescia A, Federico G, Gunaganti N, Wang Z, Yang M, Wang M, Jabali B, Yan W, Frett B, Santoro M, Carlomagno F, Li HY. Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor. Eur J Med Chem. 2025 Sep 15; 294:117735.
Score: 0.055